Letter to the Editor: ICU- and ventilator-free days with isoflurane or propofol as a primary sedative - A post- hoc analysis of a randomized controlled trial
- PMID: 37479550
- DOI: 10.1016/j.jcrc.2023.154371
Letter to the Editor: ICU- and ventilator-free days with isoflurane or propofol as a primary sedative - A post- hoc analysis of a randomized controlled trial
Keywords: Confounders to consider; Increased rate of RRT for propofol; Propofol vs isoflurane.
Conflict of interest statement
Declaration of Competing Interest The authors declare to have no competing interests.
Comment in
-
Authors response: "ICU- and ventilator-free days with isoflurane or propofol as a primary sedative - A post-hoc analysis of a randomized controlled trial".J Crit Care. 2023 Oct;77:154372. doi: 10.1016/j.jcrc.2023.154372. Epub 2023 Jul 13. J Crit Care. 2023. PMID: 37453836 No abstract available.
Comment on
-
ICU- and ventilator-free days with isoflurane or propofol as a primary sedative - A post- hoc analysis of a randomized controlled trial.J Crit Care. 2023 Dec;78:154350. doi: 10.1016/j.jcrc.2023.154350. Epub 2023 Jun 14. J Crit Care. 2023. PMID: 37327507 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
